Pfizer stock was falling Friday after the biopharmaceutical company announced that it will not be moving forward with a Phase 3 trial of its weight loss candidate.
Continue reading this article with a Barron’s subscription.
Source: finance.yahoo.com
Related posts:
We're 65, Have $1 Million Saved and $30K in Social Security Benefits. Can We Live on $70K Per Year?
1 No-Brainer Warren Buffett Dividend Stock That's a Screaming Buy for Passive Income Investors in 20...
Nikola cuts 270 jobs as cash to survive runs low
With more than 700 million views on TikTok, ‘cash-stuffing’ is one of the hottest money trends among...
Bank of America Says This ‘Buy’ Signal Could Trigger an 11% Upswing in S&P 500 Next Year — Here ...